Logo
x

Search

Subscribe Now

All Posts by Date

BeyondSpring's Plinabulin Receives the US FDA's and NMPA's Breakthrough Therapy Designations for Chemotherapy-Induced Neutropenia Indication

BeyondSpring's Plinabulin Receives the US FDA's and NMPA's Breakthrough Therapy Designations for Chemotherapy-Induced Neutropenia...

  • September 8, 2020
Boehringer Ingelheim and Pharmaxis Halt the Development of BI 1467335 for Diabetic Retinopathy

Boehringer Ingelheim and Pharmaxis Halt the Development of BI 1467335 for Diabetic Retinopathy

  • September 8, 2020
Mylan to Acquire Aspen's Thrombosis Business in the EU for ~ $758M

Mylan to Acquire Aspen's Thrombosis Business in the EU for ~ $758M

  • September 8, 2020
Sanofi Reports Results of Dupixent (dupilumab) in P-III LIBERTY ASTHMA TRAVERSE OLE Study for Asthma

Sanofi Reports Results of Dupixent (dupilumab) in P-III LIBERTY ASTHMA TRAVERSE OLE Study for Asthma

  • September 8, 2020
Roche's cobas BKV Test Receives the US FDA's 510 (k) Clearance to Improve Treatment for Transplant Patients

Roche's cobas BKV Test Receives the US FDA's 510 (k) Clearance to Improve Treatment for Transplant Patients

  • September 8, 2020
Silence Therapeutics Highlights its R&D Pipeline and Initiates Dose Escalation Studies for SLN360

Silence Therapeutics Highlights its R&D Pipeline and Initiates Dose Escalation Studies for SLN360

  • September 8, 2020
Image

Stay Connected

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2025 PharmaShots - All Rights Reserved.